Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalPublished in a peer-reviewed journal

Human Study on miRNA Expression Patterns and Multiple Sclerosis Outcomes

A study involving 54 MS patients found that dysregulation of specific microRNAs (miR-10a, miR-146a, miR-155) was significantly associated with clinical outcomes like disability scores and the appearance of cervical spinal cord lesions over roughly five years.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Not established from this source
Mechanism
Not reported
Evidence strength
Limited
Outcome
Not reported

Why it matters

These findings suggest that miRNAs could be valuable as biomarkers for monitoring disease progression in MS, pointing to possible pathways for further research.

What this does not prove

The study's associations are hypothesis-generating and need further validation in larger, prospective studies that include ongoing miRNA assessment.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Observational
Participants / samples
54 · basis not reported
Randomised
No
Controlled
Not reported
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
2026-10-23
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified
Biological target
miR-10a, miR-146a, miR-155
Pathway
Not reported
Population
Not reported
Size of effect
Not reported
Secondary endpoints
Not reported
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (19)
study designObservational
subjectsHuman
speciesHuman
sample size54
randomizedNo
publication date2026-10-23
primary endpointBetween 2015 and 2018, expression levels of miR-10a, miR-146a, and miR-155 were obtained from whole blood samples of patients with MS using RT-PCR and evaluated to investigate associations between baseline miRNA expression patterns and subsequent clinical and radiological outcomes.
follow upFollowing expression analysis, the number of relapses, annualized relapse rate, changes in Expanded Disability Status Scale (EDSS) score, radiological activity, and achievement of No Evidence of Disease Activity (NEDA-3) status were assessed over a mean follow-up period of approximately 5 years.
findingsmiR-10a dysregulation was significantly associated with the final EDSS score (P = .007) and the presence of cervical spinal cord lesions at baseline (P = .040).
findingsmiR-10a dysregulation was significantly associated with the final EDSS score (P = .007) and the presence of cervical spinal cord lesions at baseline (P = .040).
findingsmiR-146a and miR-155 dysregulation were significantly associated with the development of new cervical spinal cord lesions (P = .020 and P = .025, respectively).
findingsmiR-146a and miR-155 dysregulation were significantly associated with the development of new cervical spinal cord lesions (P = .020 and P = .025, respectively).
findingsmiR-155 also showed a nominal association with overall radiological activity (P = .049).
limitationsThese findings should be considered hypothesis-generating and require confirmation in larger prospective studies with longitudinal miRNA assessment and independent validation.
biological targetsAssociations were observed between miR-10a and disability measures, between miR-146a/miR-155 and new cervical spinal cord lesions, and between miR-155 and radiological activity.
peer reviewedPublication types: Journal Article; Observational Study
subjectsMeSH terms: Humans; MicroRNAs; Female; Retrospective Studies; Multiple Sclerosis; Adult; Male; Disease Progression; Middle Aged
subjectsPublication types: Journal Article; Observational Study
study designPublication types: Journal Article; Observational Study

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.